解读虹膜体的边界:从土壤生态学到抗炎药物
M V N L Chaitanya1, Hemanth Kumar Manikyam2, Neerugatti Dora Babu3
1School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India. mvnlcdiamond@gmail.com.
Inflammopharmacology
|August 12, 2025
概括
虹膜糖化物 (IGs) 在减少压力和炎症方面表现有前途. 需要进一步的临床试验来确认它们在人类中的适应性和免疫调节作用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
- 神经科学是一个神经科学.
背景情况:
- 虹膜糖化物 (IGs) 是具有已知的抗压力和免疫调节性质的单聚类.
- 现有研究表明IG在各种健康状况中的潜在治疗应用.
研究的目的:
- 综合分析IGs适应性和免疫性质的临床前和临床数据.
- 阐明IG作用背后的分子机制,并识别知识差距.
主要方法:
- 系统地审查和分析现有的科学文献,以化糖化物.
- 对研究特定IGs (catalpol,aucubin,geniposide,harpagoside,loganin,globularifolin) 作用的临床前和临床研究的审查.
主要成果:
- 口服IGs通过影响皮质激素,BDNF和COX-2水平来减轻压力和抑郁症.
- 在糖尿病脑病变和性氧化应激模型中,IGs改善了认知和线粒体功能.
- 特定的IGs通过抑制NF-κB等途径和激活Nrf2/HO-1来表现出抗炎作用.
结论:
- 虹膜糖化物具有显著的适应性和免疫调节潜力.
- 建议进一步进行精心设计的临床试验,以验证IGs在人类减轻压力和免疫调节方面的有效性.
- 本综述强调了IGs作为新疗法的潜在治疗线索.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
236
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
236
Inflammatory Bowel Disease IV: Pharmacological Management
177
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
177
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
264
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
264
The Roles of Bacteria and Fungi in Plant Nutrition
40.6K
Plants have the impressive ability to create their own food through photosynthesis. However, plants often require assistance from organisms in the soil to acquire the nutrients they need to function correctly. Both bacteria and fungi have evolved symbiotic relationships with plants that help the species to thrive in a wide variety of environments.
40.6K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
200
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
200
Drugs for Treatment of Diarrhea-Predominant IBS
289
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
289


